United HomepageClinical Trial, Open for Enrollment: A Phase II Study of High-Dose Immunosuppressive Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) + Thymoglobulin, and Autologous CD34+ Hematopoietic Stem Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple SclerosisMonday, December 15th, 2008A Multiple Sclerosis clinical trial is now open for enrollment. It is a phase II study aimed at the treatment of poor prognosis Multiple Sclerosis. NARCOMS Report-Exercise ParticipationSaturday, December 6th, 2008NARCOMS looks at the role of physical activity in the treatment and management of Multiple Sclerosis. Paroxysmal Symptoms of Multiple Sclerosis: They Come and They GoTuesday, November 18th, 2008Many people with MS often confuse a pseudoexacerbation with a true MS exacerbation. The symptoms are similar, but the duration and underlying cause are not. Health Benefits of YogaWednesday, November 5th, 2008What do you think of when you hear the word Yoga? This article dispels the pretzel postures myth and offers views on a much more gentle therapy. Diagnostic Criteria for MSMonday, September 22nd, 2008Diagnosing Multiple Sclerosis. Dr. Roberto Bomprezzi goes into detail on the criteria and difficulty in early diagnosis of MS. Functional Electrical Stimulation and Multiple Sclerosis: Seperating Fact from FictionFriday, August 29th, 2008Functional electrical stimulation and Multiple Sclerosos- Get the facts from Brian Hutchinson, PT, MSCS-CEO. Hispanic/Latino NARCOMS ParticipantsThursday, August 7th, 2008North American Research Committee on Multiple Sclerosis summary of Registry participants who have identified themselves as Hispanic or Latino. |
|